Levomedetomidine
CAS: 119717-21-4
Ref. 3D-UEA71721
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- 1H-Imidazole,4-[1-(2,3-dimethylphenyl)ethyl]-, (R)-
- (-)-Medetomidine
- (R)-Medetomidine
- Mpv 1441
- l-Medetomidine
Levomedetomidine is a sedative-hypnotic agent that belongs to the class of α2-adrenergic agonists. It has a variety of physiological effects, including anesthetic and analgesic properties. Levomedetomidine has been shown to have a high degree of solubility in water, which is greater than dexmedetomidine. Levomedetomidine also causes a decrease in intracellular Ca2+ levels in the brain, which may be due to its ability to activate the Toll-like receptor 4 (TLR4) and TLR7 receptors on microglia. These receptors are found on cells that release proinflammatory cytokines, such as tumor necrosis factor alpha (TNFα). This drug also has an anti-inflammatory effect due to its ability to inhibit the production of inflammatory mediators by inhibiting the activity of TNFα and other proinflammatory mediators.
Propriedades químicas
Consulta técnica sobre: 3D-UEA71721 Levomedetomidine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
